.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
AstraZeneca
McKinsey
Mallinckrodt
Federal Trade Commission
Teva
Queensland Health
Boehringer Ingelheim
Johnson and Johnson
Novartis

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: meclofenamate sodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071081ANDAMylan Pharmaceuticals Inc.0378-2150-01100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2150-01)
Mylan
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071081ANDAMylan Pharmaceuticals Inc.0378-3000-01100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3000-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Dow
McKinsey
Covington
Chinese Patent Office
Julphar
Baxter
Johnson and Johnson
QuintilesIMS
Fish and Richardson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot